Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dendritic enriched secreted lymphocyte activation molecule

Dendritic enriched secreted lymphocyte activation molecule

US Patent 6620912 · Granted Sep 16, 2003

Estimated economic value: $13,221,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vascular endothelial growth factor 22016
Albumin fusion proteins2016
Albumin fusion proteins2015
Antibodies that immunospecifically bind to B lymphocyte stimulator protein2015
Albumin fusion proteins2015
Nucleic acid enzymes and complexes and methods for their use2015
Vascular endothelial growth factor 22014
Methods of inhibiting proliferation or immunoglobulin production of B cells usin2013
Albumin fusion proteins2013
Respiratory syncytial virus (RSV) viral load detection assay2013
HWBAO62 polypeptides2013
12 human secreted proteins2013